CYP7B1-mediated 25-hydroxycholesterol degradation maintains quiescence-activation balance and improves therapeutic potential of mesenchymal stem cells.
Zhang Z, Su Z, Li Z, Li J, Yu W, Ye G, Lin J, Che Y, Xu P, Zeng Y, et al. Cell Chem Biol. 2024 Jul 18; 31(7):1277-1289.e7. Epub 2024 Feb 20.